In February 2026, Bayer announced a $7.25 billion class-action settlement plan from its subsidiary Monsanto that would resolve current and future cancer claims related to the use of Roundup weed killer.
If the settlement plan is accepted in court, it would award payments to lawsuit participants diagnosed with Non-Hodgkin’s Lymphoma—alive or deceased—for up to 21 years. However, a certain number of claimants must opt-in to the settlement for it to be approved, and those individuals would lose the ability to fight for a potentially larger settlement in court.
As of this year, over 60,000 Roundup cases have not yet been resolved, and legal experts expect for thousands of new cases to be filed.
How does opting in for the settlement work?
Before lawsuit participants get the opportunity to opt-in, the court must first provide an initial approval of Bayer and Monsanto’s settlement proposal. If the overseeing judge denies their plan, then the settlement offer will be cancelled and lawyers will proceed with cases as normal.
If the settlement proposal is approved, Non-Hodgkin’s Lymphoma patients who wish to opt-in will be able to either file a new claim—if they have not already filed a Roundup claim before—or transfer their existing mass tort claims into the class-action settlement plan by working directly with their attorneys.
Claimants who do NOT wish to participate in the settlement plan will have the opportunity to opt-out and continue pursuing compensation through an individual mass tort.
What does the recent executive order mean for the settlement plan?
At this time, the February 2026 executive order issued by the Trump administration to protect the production of “glyphosate-based herbicides” like Roundup does not appear to have any immediate bearing on existing claims. But, if the order remains unblocked, then it could be possible for the partial legal immunity Bayer/Monsanto were recently given to have an impact on new claims being filed.
As of now, the scope of exactly how much the 2026 executive order could affect claims has yet to be determined. Some legal experts and advocacy groups argue that the executive order is “legally meritless” and provides no real power for Bayer and Monsanto. Other legal and financial analysts, on the other hand, argue that it plays a major role in Bayer and Monsanto’s strategy to eventually eliminate Roundup claims for good through the U.S. Supreme Court.
Join the Roundup lawsuit
As legal experts continue to evaluate what the executive order will ultimately mean for the lawsuit, lawyers will still be accepting new Roundup claims and pursuing existing cases in court.
If you or someone you love developed Non-Hodgkin’s Lymphoma, Chronic Lymphocytic Leukemia, B-Cell Lymphoma, T-Cell Lymphoma, or another type of blood cancer after using Roundup weed killer, check your eligibility now to see if you qualify for compensation today.
